Finanzwire Finanzwire
Basculer en Français
9984 Companies
202390 Keywords
133028 Articles
107483 Press releases
Headlines Articles Press releases Nemysis Limited Remove
  1. Home
  2. Companies
  3. Nemysis Limited
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/23/2024 at 10:05, 1 year 9 months ago

    Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

    Nutritional Supplement IHAT Patent Iron Deficiency Nemysis Limited
  • PRESS RELEASE

    published on 05/23/2024 at 10:00, 1 year 9 months ago

    Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

    Nemysis strengthens IP portfolio with new patent (WO2021204705) for IHAT oral iron supplement, safe for iron deficiency treatment. Dr. Comelli and Dr. Faria comment on significance
    IHAT Patent IP Portfolio Iron Deficiency Nemysis
    Logo of Nemysis Limited
  • PRESS RELEASE

    published on 01/10/2024 at 17:00, 2 years 1 month ago

    Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement

    Nemysis Ltd and Kolinpharma® SpA have signed a non-exclusive sales and marketing agreement for IHAT (Iron Hydroxide Adipate Tartrate), Nemysis' innovative oral iron supplementation product. This partnership aims to enhance coverage of the target markets within Italy, one of the largest in Europe, and improve access to effective iron deficiency solutions.
    Nemysis Ltd Kolinpharma® SpA IHAT Iron Supplementation Italy Market
    Logo of Nemysis Limited
Accesswire
  • Published on 03/05/2026 at 17:55, 1 hour 10 minutes ago

    ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026

  • Published on 03/05/2026 at 14:00, 5 hours 5 minutes ago

    EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada

  • Published on 03/05/2026 at 14:00, 5 hours 5 minutes ago

    GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report

  • Published on 03/05/2026 at 14:00, 5 hours 5 minutes ago

    Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters

  • Published on 03/05/2026 at 13:40, 5 hours 25 minutes ago

    Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

View all ACCESSWIRE
EQS Group
  • Published on 03/05/2026 at 18:48, 17 minutes ago

    POS-Transaction in Own Shares

  • Published on 03/05/2026 at 18:17, 48 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 03/05/2026 at 17:57, 1 hour 8 minutes ago

    EQS-Adhoc: Delivery Hero SE may redeem convertible bonds in H1 2026 using proceeds from a USD 1.5bn increase of its term loans subject to certain conditions

  • Published on 03/05/2026 at 17:48, 1 hour 16 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 03/05/2026 at 17:45, 1 hour 20 minutes ago

    Swiss Prime Site announces the conversion price of its CHF 350 million green convertible bonds due 2032 and the outcome of the incentivized conversion invitation

View all EQS
Les Echos
  • Published on 03/05/2026 at 18:40, 25 minutes ago

    2025 Full-year results FREY: a pan-European platform already creating value

  • Published on 03/05/2026 at 18:34, 30 minutes ago

    Mersen: Number of shares and voting rights as of February 28, 2026

  • Published on 03/05/2026 at 17:45, 1 hour 20 minutes ago

    February 2026

  • Published on 03/05/2026 at 17:45, 1 hour 20 minutes ago

    Cie du Bois Sauvage : Results 2025

  • Published on 03/05/2026 at 13:20, 5 hours 45 minutes ago

    Voting rights

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy